← Portfolio Scout

Portfolio company

Hylomorph

Switzerland · £4.5m raised

Raised

£4.5m

Latest stage

Series B

Rounds recorded

1

Backed by

5 investors

Sectors

Digital Health

About

Hylomorph develops biosynthetic cellulose membranes and pouches to prevent fibrotic encapsulation and post-operative complications for patients receiving cardiac and neurostimulation medical implants.

Source

Funding history · 1

Similar companies